美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Pernix Therapeutics Holdings

0.2070

0.0000

成交量：- -

成交额：- -

市值：300.27万

市盈率：-0.03

高：0.2070

开：0.2070

低：0.2070

收：0.2070

52周最高：3.30

52周最低：0.2030

股本：1,450.58万

流通股本：1,332.22万

量比：- -

换手率：- -

股息：- -

股息率：- -

每股收益(TTM):-6.2602

每股收益(LYR):-7.2054

净资产收益率：--

总资产收益率：--

市净率：-0.01

市盈率(LYR):-0.03

数据加载中...

总览公司新闻资讯公告

公司资料

公司名字：

Pernix Therapeutics Holdings

交易所：

NASDAQ

成立时间：

- -

员工人数：

- -

公司地址：

- -

官网：

http://www.pernixtx.com

邮编：

- -

电话：

- -

传真：

- -

简介：

Pernix Therapeutics Holdings, Inc.于1996年11月8日在马里兰州注册成立。公司是一家特种药物生产企业，主要对一系列品牌及基因医药产品进行售卖、市场营销、生产和研发，这些医药产品主要应用于失眠、细菌感染以及咳嗽和感冒症状。公司希望通过酌情把其产品推销给内科医生、卫生保健行业从业者以及顾客，以此来预见公司业绩的持续增长。自成立之日起，公司便参与了多项并购重组以及许可证协议，以此希望扩大其产品销售渠道。作为其部分扩张战略，公司计划对其他产品和公司进行战略收购，同时研发并引进额外产品，其目的是将慢性、非季节性的特种产品引入到其利润范围中。其品牌产品包括先力腾（CEDAX），它是治疗中耳炎的抗生素类药物，同时也是治疗咳嗽和感冒的处方药（包括ZUTRIPRO, REZIRA和VITUZ）。公司还对多赛平（SILENOR）进行市场营销，该物可以治疗失眠症（对睡眠维持有困难），同时不受买卖控制。公司通过售卖及市场营销组织宣传其品牌药物。

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"澳洲华人首选美澳港股一站式交易平台 | 老虎证券","description":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","keywords":"老虎证券,老虎证券澳洲,老虎证券股票,老虎证券开户,老虎证券app,tigertrade老虎证券,股票,asx美股,炒股,券商,澳洲股票交易,澳大利亚炒股","social":{"ogDescription":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/PTX/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"PTX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTX\",,,,,undefined,":{"symbol":"PTX","market":"US","secType":"STK","nameCN":"Pernix Therapeutics Holdings","latestPrice":0.207,"timestamp":1552680000000,"preClose":0.207,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":13322183,"shares":14505848,"eps":-6.260195,"marketStatus":"已收盘","change":0,"latestTime":"03-15 16:00:00 EDT","open":0.207,"high":0.207,"low":0.207,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-6.260195,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1773993600000},"marketStatusCode":5,"adr":0,"adrRate":0,"listingDate":855291600000,"exchange":"NASDAQ","adjPreClose":0.207,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTX\",,,,,undefined,":{"symbol":"PTX","floatShares":13322183,"roa":"--","roe":"--","lyrEps":-7.205398,"shares":14505848,"dividePrice":0,"high":0.207,"amplitude":0,"preClose":0.207,"low":0.207,"week52Low":0.203,"pbRate":"-0.01","week52High":3.3,"institutionHeld":0.7448,"latestPrice":0.207,"eps":-6.260195,"divideRate":0,"volume":0,"delay":0,"ttmEps":-6.260195,"open":0.207,"prevYearClose":0.207},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PTX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2018-11-08","symbol":"PTX","fiscalQuarterEnding":"2018/09","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1541653200000,"reportTimeType":"","actualEps":-0.89},{"market":"US","date":"2018-08-09","symbol":"PTX","fiscalQuarterEnding":"2018/06","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1533787200000,"reportTimeType":"","actualEps":-1.13},{"market":"US","date":"2018-05-10","symbol":"PTX","fiscalQuarterEnding":"2018/03","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1525924800000,"reportTimeType":"","actualEps":-1.57},{"market":"US","date":"2018-03-08","symbol":"PTX","fiscalQuarterEnding":"2017/12","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1520485200000,"reportTimeType":"","actualEps":-2.78},{"market":"US","date":"2017-11-07","symbol":"PTX","fiscalQuarterEnding":"2017/09","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1510030800000,"reportTimeType":"","actualEps":-0.57}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PTX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PTX\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.pernixtx.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.022},{"period":"1month","weight":-0.0298},{"period":"3month","weight":-0.0222},{"period":"6month","weight":-0.0034},{"period":"1year","weight":0.179},{"period":"ytd","weight":-0.03}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Pernix Therapeutics Holdings, Inc.于1996年11月8日在马里兰州注册成立。公司是一家特种药物生产企业，主要对一系列品牌及基因医药产品进行售卖、市场营销、生产和研发，这些医药产品主要应用于失眠、细菌感染以及咳嗽和感冒症状。公司希望通过酌情把其产品推销给内科医生、卫生保健行业从业者以及顾客，以此来预见公司业绩的持续增长。自成立之日起，公司便参与了多项并购重组以及许可证协议，以此希望扩大其产品销售渠道。作为其部分扩张战略，公司计划对其他产品和公司进行战略收购，同时研发并引进额外产品，其目的是将慢性、非季节性的特种产品引入到其利润范围中。其品牌产品包括先力腾（CEDAX），它是治疗中耳炎的抗生素类药物，同时也是治疗咳嗽和感冒的处方药（包括ZUTRIPRO, REZIRA和VITUZ）。公司还对多赛平（SILENOR）进行市场营销，该物可以治疗失眠症（对睡眠维持有困难），同时不受买卖控制。公司通过售卖及市场营销组织宣传其品牌药物。","exchange":"NASDAQ","name":"Pernix Therapeutics Holdings","nameEN":"Pernix Therapeutics"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"PTX\",market:\"US\",,,undefined,":null}}